EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammation in atherosclerosis: Lessons and therapeutic implications

Peter Libby, Oliver Soehnlein

Immunity · 2025-10 · 58 (10) · 2383-2401

DOI: 10.1016/j.immuni.2025.09.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunity, 2025-10. Verfasst von Peter Libby und 1 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Vascular Institute Mass General Brigham Hospital and Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Inflammation, Atherosclerosis. Die Arbeit wurde bisher 123-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart, Lung, and Blood Institute, HORIZON EUROPE Framework Programme, Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory pathways operate at all stages of atherosclerosis. These processes are driven by risk factors and other stimuli that can spark inflammation by eliciting misdirected responses of intrinsic vascular cells and leukocytes, culminating in lesion initiation, progression, and complication. Continuing dissection of the key underlying inflammatory mechanisms with increasingly sophisticated tools has inspired successful clinical trials and enabled translation to the clinic. Here, we review the mechanistic understanding of the etiology and progression of atherosclerosis. We discuss how cardiovascular risk factors converge at the level of the bone marrow to perturb hematopoiesis, yielding output with a pro-inflammatory slant. We further consider how circulating myeloid cells enter, propagate, and persist in atherosclerotic lesions and how intimal macrophages take center stage in regulating the inflammatory milieu. In this context, we delineate emerging therapeutic strategies aimed at mitigating inflammation in atherosclerosis and how these add to existing measures toward reducing the global cardiovascular disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationAtherosclerosisHumansAnimalsAnti-Inflammatory AgentsRisk FactorsMacrophagesCytokines

Stichwörter der Autor:innen

atherosclerosiscardiovascular diseasehematopoiesisinflammationmacrophagesneutrophils

Substanzen

Anti-Inflammatory AgentsCytokines

Autor:innen und Institutionen

  • Heart and Vascular Institute Mass General Brigham Hospital and Harvard Medical School, Boston, MA, USA.
  • Institute of Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation (ZMBE), University Hospital Münster, University of Münster, Münster, Germany. Electronic address: soehnlein@uni-muenster.de.

Förderung

  • National Heart, Lung, and Blood Institute
  • HORIZON EUROPE Framework Programme
  • Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
  • German Research Foundation
  • International Monetary Fund
  • Novo Nordisk
  • Else Kröner-Fresenius-Stiftung

Zitieren

APA

Libby, P., & Soehnlein, O. (2025). Inflammation in atherosclerosis: Lessons and therapeutic implications. Immunity, 58(10), 2383-2401. https://doi.org/10.1016/j.immuni.2025.09.012

Vancouver

Libby P, Soehnlein O. Inflammation in atherosclerosis: Lessons and therapeutic implications. Immunity. 2025;58(10):2383-2401. doi:10.1016/j.immuni.2025.09.012

BibTeX
@article{Libby2025,
  author = {Libby, Peter and Soehnlein, Oliver},
  title = {Inflammation in atherosclerosis: Lessons and therapeutic implications},
  journal = {Immunity},
  year = {2025},
  volume = {58},
  number = {10},
  pages = {2383--2401},
  doi = {10.1016/j.immuni.2025.09.012}
}
Kostenlos starten →